Menu Back to 7th-DIA-CMC-Forum-in-Japan

Overview

This Program will be conducted only in Japanese. No interpretation will be available.

We look forward to welcoming you at Nihonbashi Life Science HUB on June 18, 2018 for stimulating discussion!

Program Committee

  • Noriko  Katori, PhD
    Noriko Katori, PhD Division of Drugs
    National Institute of Health Sciences, Japan
  • Takeshi  Hamaura, PhD
    Takeshi Hamaura, PhD Vice President, CMC Planning Department, Pharmaceutical Technology Division
    Daiichi Sankyo Co., Ltd., Japan
  • Yukio  Hiyama, PhD
    Yukio Hiyama, PhD Visiting Researcher
    National Institute of Health Sciences, Japan
  • Fusashi  Ishikawa, PhD, MSc
    Fusashi Ishikawa, PhD, MSc Director, Formulation Property Research Group, Formulation R&D Laboratories
    Sumitomo Dainippon Pharma Co., Ltd., Japan
  • Yoshihiro  Matsuda, PhD
    Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Tomonori  Nakagawa
    Tomonori Nakagawa Production HQ Manufacturing Process Development Department (API)
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Haruhiro  Okuda, PhD
    Haruhiro Okuda, PhD Deputy Director General
    National Institute of Health Sciences, Japan
  • Tomoaki  Sakamoto, PhD
    Tomoaki Sakamoto, PhD Section Chief
    National Institute of Health Sciences, Japan
  • Kazunori  Takagi, PhD
    Kazunori Takagi, PhD Deputy Review Director, Office of Generic Drugs
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Jun  Yamada
    Jun Yamada Senior Manager, Global CMC NCE-Japan & East Asia
    Pfizer Japan Inc., Japan
Load More

Contact us


Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574

Digital Learning Catalog

DIA Learning: 2018 eLearning Soultions
Download